Aurora Cannabis Inc. (ACB) vs Eupraxia Pharmaceuticals Inc. (EPRX)
A side-by-side comparison of Aurora Cannabis Inc. and Eupraxia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACB
Aurora Cannabis Inc.
$4.60HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
EPRX
Eupraxia Pharmaceuticals Inc.
$7.73HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ACB vs EPRX
growth of $100 · dividends reinvested · last 2yACB -38.1% (-21.3%/yr)EPRX +162.7% (+62.1%/yr)EPRX compounded faster over this window
ACB EPRX
ACB vs EPRX: by the numbers
- •ACB is the larger company ($285M vs $259M market cap).
- •Both run net losses; EPRX's is the smaller (0.00% vs -38.13% net margin).
Metrics side by side
Valuation
| Metric | ACB | EPRX |
|---|---|---|
| P/S ratio | 1.37 | N/A |
| P/B ratio | 0.77 | 2.55 |
Profitability
| Metric | ACB | EPRX |
|---|---|---|
| Gross margin | 42.62% | 0.00% |
| Operating margin | -14.55% | 0.00% |
| Net margin | -38.13% | 0.00% |
| ROE | -21.41% | -38.33% |
| ROIC | -15.69% | -43.56% |
Growth (annualized)
| Metric | ACB | EPRX |
|---|---|---|
| Revenue CAGR (5Y) | 1.68% | N/A |
| Total return CAGR (5Y) | -42.83% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.